Skip to main content

Chris Cain

Equibles does not estimate personal net worth.

Get an email with a short summary when Damora Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get DMRA alerts

About Chris Cain

Chris Cain is recorded as Board Member at Damora Therapeutics, Inc. (DMRA) since November 10, 2025. Damora Therapeutics, Inc. reported in an 8-K filed November 10, 2025 that Chris Cain was appointed Board, effective November 10, 2025. Damora Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Damora Therapeutics, Inc. includes Jennifer Jarrett (CEO and Board Member), Sherwin Sattarzadeh (CEO and COO), Peter Harwin (Chairman and Board Member) and 7 others.

“Peter Harwin, Chris Cain, Ph.D., and Julianne Bruno were appointed to the Board as directors.”
Damora Therapeutics, Inc. Form 8-K, filed November 10, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at Damora Therapeutics, Inc.

Recent activity